- 全部删除
您的购物车当前为空
SHO1122147 (Compound 7m) 通过影响线粒体电子传递链展现出线粒体解偶联活性(EC50=3.6 μM),提升细胞耗氧率(OCR=69%)并促进细胞呼吸。SHO1122147 具备口服活性,适用于肥胖和代谢功能障碍相关脂肪性肝炎 (MASH) 的研究。

SHO1122147 (Compound 7m) 通过影响线粒体电子传递链展现出线粒体解偶联活性(EC50=3.6 μM),提升细胞耗氧率(OCR=69%)并促进细胞呼吸。SHO1122147 具备口服活性,适用于肥胖和代谢功能障碍相关脂肪性肝炎 (MASH) 的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
SHO1122147 相关产品
| 产品描述 | SHO1122147 (Compound 7m) disrupts the mitochondrial electron transport chain, demonstrating mitochondrial uncoupling activity (EC50=3.6 μM). It increases the cellular oxygen consumption rate (OCR=69%) and enhances cellular respiration. Additionally, SHO1122147 is orally active and can be utilized in research related to obesity and metabolic dysfunction-associated steatohepatitis (MASH). |
| 分子量 | 338.748 |
| 分子式 | C17H11ClN4O2 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容